New Potential Therapies for Chronic Hepatitis B / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 267-273, 2019.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-761567
Responsible library:
WPRO
ABSTRACT
A HBV infection is a dynamic disease and long-term liver inflammation contributes to the development of liver cirrhosis and hepatocellular carcinoma. Currently available nucleos(t)ide analogues and pegylated interferon are effective in inhibiting HBV replication but rarely achieve HBsAg clearance. The present article introduces a new definition of HBV cure and several emerging therapies for HBV cure, including direct acting antivirals and immune modulatory antivirals.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Hepatitis B virus
/
Interferons
/
Carcinoma, Hepatocellular
/
Hepatitis B, Chronic
/
Hepatitis B Surface Antigens
/
Hepatitis, Chronic
/
Inflammation
/
Liver
/
Liver Cirrhosis
Language:
Korean
Journal:
The Korean Journal of Gastroenterology
Year:
2019
Document type:
Article
